[go: up one dir, main page]

MX2017007670A - Metodo de manufactura de proteina. - Google Patents

Metodo de manufactura de proteina.

Info

Publication number
MX2017007670A
MX2017007670A MX2017007670A MX2017007670A MX2017007670A MX 2017007670 A MX2017007670 A MX 2017007670A MX 2017007670 A MX2017007670 A MX 2017007670A MX 2017007670 A MX2017007670 A MX 2017007670A MX 2017007670 A MX2017007670 A MX 2017007670A
Authority
MX
Mexico
Prior art keywords
protein
manufacturing
protein manufacture
manufacture
coupled
Prior art date
Application number
MX2017007670A
Other languages
English (en)
Other versions
MX381459B (es
Inventor
Mark ILLIDGE Christopher
Alan Watson Neil
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of MX2017007670A publication Critical patent/MX2017007670A/es
Publication of MX381459B publication Critical patent/MX381459B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a un método novedosos para manufacturar una proteína, particularmente donde tal proteína está siendo acoplada con otra molécula. La invención proporciona además, un método para manufacturación de proteína a escala industrial para obtener proteínas, por ejemplo, para propósitos terapéuticos.
MX2017007670A 2014-12-22 2015-12-18 Metodo de manufactura de proteina. MX381459B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199722 2014-12-22
PCT/EP2015/080526 WO2016102378A1 (en) 2014-12-22 2015-12-18 Method of protein manufacture

Publications (2)

Publication Number Publication Date
MX2017007670A true MX2017007670A (es) 2017-10-27
MX381459B MX381459B (es) 2025-03-12

Family

ID=52282495

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007670A MX381459B (es) 2014-12-22 2015-12-18 Metodo de manufactura de proteina.

Country Status (24)

Country Link
US (1) US10626143B2 (es)
EP (1) EP3237433B1 (es)
JP (1) JP6807326B2 (es)
KR (1) KR102537099B1 (es)
CN (1) CN107108691B (es)
AU (1) AU2015371341B2 (es)
BR (1) BR112017013398B1 (es)
CA (1) CA2969981C (es)
CL (1) CL2017001633A1 (es)
CO (1) CO2017006157A2 (es)
DK (1) DK3237433T3 (es)
EA (1) EA039002B1 (es)
ES (1) ES3046837T3 (es)
FI (1) FI3237433T3 (es)
HR (1) HRP20251240T1 (es)
IL (1) IL252712B2 (es)
LT (1) LT3237433T (es)
MX (1) MX381459B (es)
MY (1) MY184085A (es)
PL (1) PL3237433T3 (es)
PT (1) PT3237433T (es)
SG (1) SG11201704841UA (es)
SI (1) SI3237433T1 (es)
WO (1) WO2016102378A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3237432T1 (sl) 2014-12-22 2023-12-29 UCB Biopharma SRL Izdelava proteinov
EP3558363A1 (en) 2016-12-21 2019-10-30 Amgen Inc. Anti-tnf alpha antibody formulations
CN110386978A (zh) * 2018-04-19 2019-10-29 上海多米瑞生物技术有限公司 大肠杆菌周质空间表达的蛋白的提取方法
CN111965356B (zh) * 2019-11-28 2023-09-08 上海荣盛生物药业股份有限公司 巯基还原组合物及荧光微球层析试纸和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5655866A (en) 1995-03-20 1997-08-12 Bellanca; Joseph V. Method of folding a signature for use in bookbinding
CA2364568A1 (en) * 1999-03-17 2000-09-21 Adrian Woolfson Method for refolding molecules of polypeptides containing ig domains
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
JP5553963B2 (ja) * 2004-10-22 2014-07-23 アムジエン・インコーポレーテツド 組換え抗体をリフォールディングする方法
EP1805205A1 (en) * 2004-10-22 2007-07-11 Amgen Inc. Methods for refolding polypeptides
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0513852D0 (en) 2005-07-06 2005-08-10 Celltech R&D Ltd Biological products
ZA200900229B (en) 2006-07-14 2010-04-28 Genentech Inc Refolding of recombinant proteins
EP2102355B1 (en) * 2006-12-14 2016-03-02 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
KR101853146B1 (ko) 2010-03-17 2018-04-27 라티오팜 게엠베하 생물학적으로 활성인 재조합 인간 ｇ­ｃｓｆ의 수득 방법
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
GB201012603D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
CA2815342A1 (en) 2010-10-20 2012-04-26 Medimmune, Llc Methods for processing inclusion bodies
SI3237432T1 (sl) 2014-12-22 2023-12-29 UCB Biopharma SRL Izdelava proteinov
GB201506870D0 (en) 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method

Also Published As

Publication number Publication date
EA201791423A1 (ru) 2017-10-31
CN107108691B (zh) 2021-06-29
MY184085A (en) 2021-03-17
HRP20251240T1 (hr) 2025-12-05
AU2015371341B2 (en) 2021-05-20
IL252712A0 (en) 2017-08-31
EA039002B1 (ru) 2021-11-19
ES3046837T3 (en) 2025-12-02
IL252712B1 (en) 2023-12-01
PL3237433T3 (pl) 2025-12-08
CL2017001633A1 (es) 2017-11-24
PT3237433T (pt) 2025-10-21
CO2017006157A2 (es) 2017-09-20
BR112017013398A2 (pt) 2018-03-06
JP2018505210A (ja) 2018-02-22
FI3237433T3 (fi) 2025-10-14
LT3237433T (lt) 2025-11-10
EP3237433A1 (en) 2017-11-01
KR20170090510A (ko) 2017-08-07
SI3237433T1 (sl) 2025-11-28
KR102537099B1 (ko) 2023-05-25
AU2015371341A1 (en) 2017-06-29
SG11201704841UA (en) 2017-07-28
US10626143B2 (en) 2020-04-21
DK3237433T3 (da) 2025-10-20
CN107108691A (zh) 2017-08-29
IL252712B2 (en) 2024-04-01
WO2016102378A1 (en) 2016-06-30
US20170342105A1 (en) 2017-11-30
CA2969981C (en) 2024-06-25
JP6807326B2 (ja) 2021-01-06
MX381459B (es) 2025-03-12
CA2969981A1 (en) 2016-06-30
BR112017013398B1 (pt) 2023-12-05
EP3237433B1 (en) 2025-07-30

Similar Documents

Publication Publication Date Title
CY1123642T1 (el) Αντισωματα enanti-pd-1
EA201891339A1 (ru) Водный фармацевтический препарат, который содержит антитело к pd-l1 авелумаб
CY1124521T1 (el) Σκευασματα αντισωματος anti-cd19
HUE071193T2 (hu) Sejtek transzfekció utáni korai izolálása (EPIC) biologikumok elõállításához
MX375524B (es) Anticuerpos anti-axl.
MX2015013202A (es) Cultivo, produccion, procesamiento y uso de cannabis de especialidad.
MX390701B (es) Manufactura de proteína.
EP3280267C0 (en) PROTEASE FOR THE PRODUCTION OF HIGH-PROTEIN FERMENTED DAIRY PRODUCTS
BR112017001391A2 (pt) componentes para o fusionamento de corpos vertebrais
BR112017005109A2 (pt) produto refratário com base em al2o3, composição de matérias-primas para a fabricação do produto, método para a fabricação de um produto refratário, produto refratário, e emprego do produto refratário
CY1122578T1 (el) Φαρμακευτικο σκευασμα το οποιο περιλαμβανει αντισωμα
CL2017000087A1 (es) Un proceso novedoso para la purificación de rhu-gcsf
IT201700068744A1 (it) Processo per la produzione di acido levulinico.
BR112016019390A2 (pt) proteínas de fusão uti
CO2018010286A2 (es) Método para la purificación de proteínas
EP3377633C0 (en) PRODUCTION OF RECOMBINANT PROTEINS
MX2017007670A (es) Metodo de manufactura de proteina.
CO2017010143A2 (es) Procesos para preparar fluorocetólidos
BR112017018993A2 (pt) Processo para preparar 3-cloro-2- vinilfenilassulfonatos
BR112016019246A2 (pt) processo paraa fabricação de hidroclorofluoro-olefinas
MX382659B (es) Proceso para la preparación de derivados de tiazol.
CL2017001383A1 (es) Proceso para la fabricación de anhídrido carboxílico
MX382631B (es) Proceso para la preparacion de derivados dihidroisoxazol.
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
MX384260B (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.